Clinical Trial Update: Single-dose Pharmacokinetics of Pociredir in Participants With Sickle Cell Disease [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating the single-dose pharmacokinetics of Pociredir in participants with sickle cell disease. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease

Drugs mentioned

• Pociredir

Snippet

Sponsor: Fulcrum Therapeutics | Conditions: Sickle Cell Disease | Phase 1 | Status: RECRUITING